Connection

Co-Authors

This is a "connection" page, showing publications co-authored by JOSEPH SPINNER and WILLIAM DREYER.
Connection Strength

1.536
  1. SARS-CoV-2 anti-spike antibodies after vaccination in pediatric heart transplantation: A first report. J Heart Lung Transplant. 2022 02; 41(2):133-136.
    View in: PubMed
    Score: 0.201
  2. "Compassionate" Cases of the Jarvik 2015 Ventricular Assist Device. ASAIO J. 2021 09 01; 67(9):1036-1043.
    View in: PubMed
    Score: 0.198
  3. Hospital outcomes for pediatric heart transplant recipients undergoing tracheostomy: A multi-institutional analysis. Pediatr Transplant. 2021 May; 25(3):e13904.
    View in: PubMed
    Score: 0.188
  4. Fecal microbiota transplantation in a toddler after heart transplant was a safe and effective treatment for recurrent Clostridiodes difficile infection: A case report. Pediatr Transplant. 2020 02; 24(1):e13598.
    View in: PubMed
    Score: 0.174
  5. Association of Late Gadolinium Enhancement and Degree of Left Ventricular Hypertrophy Assessed on Cardiac Magnetic Resonance Imaging With Ventricular Tachycardia in Children With Hypertrophic Cardiomyopathy. Am J Cardiol. 2016 Apr 15; 117(8):1342-8.
    View in: PubMed
    Score: 0.135
  6. Atypical infiltrates on endomyocardial biopsy are associated with adverse outcomes in pediatric heart transplantation. J Heart Lung Transplant. 2023 12; 42(12):1743-1752.
    View in: PubMed
    Score: 0.056
  7. Arrhythmogenic cardiomyopathy is under-recognized in end-stage pediatric heart failure: A 36-year single-center experience. Pediatr Transplant. 2023 03; 27(2):e14442.
    View in: PubMed
    Score: 0.054
  8. Relation of Low Chloride Concentration to Diuretic Efficiency and Transplant-Free Survival in Children Hospitalized With Heart Failure. Am J Cardiol. 2022 12 01; 184:72-79.
    View in: PubMed
    Score: 0.053
  9. Bivalirudin or Unfractionated Heparin for Anticoagulation in Pediatric Patients on Continuous Flow Ventricular Assist Device Support: Single-Center Retrospective Cohort Study. Pediatr Crit Care Med. 2022 10 01; 23(10):e465-e475.
    View in: PubMed
    Score: 0.052
  10. Ventricular assist device support for children with chemotherapy-induced cardiomyopathy and advanced heart failure: Perspectives gained from a single-center experience. Pediatr Transplant. 2022 08; 26(5):e14286.
    View in: PubMed
    Score: 0.052
  11. Does Cardiac Catheterization Facilitate Hemodynamic Optimization of Pediatric Patients on Continuous-Flow Ventricular Assist Devices? ASAIO J. 2022 04 01; 68(4):584-591.
    View in: PubMed
    Score: 0.052
  12. LMOD2-related dilated cardiomyopathy presenting in late infancy. Am J Med Genet A. 2022 06; 188(6):1858-1862.
    View in: PubMed
    Score: 0.051
  13. Trends in Body Mass Index and Association With Outcomes in Pediatric Patients on Continuous Flow Ventricular Assist Device Support. ASAIO J. 2022 09 01; 68(9):1182-1190.
    View in: PubMed
    Score: 0.051
  14. Outcomes following use of pediatric and young adult donor hearts with bicuspid aortic valves: A single-center case series. Pediatr Transplant. 2022 05; 26(3):e14212.
    View in: PubMed
    Score: 0.051
  15. Poor efficacy of oral iron replacement therapy in pediatric patients with heart failure. Cardiol Young. 2022 Aug; 32(8):1302-1309.
    View in: PubMed
    Score: 0.050
  16. Pediatric heart-liver transplant outcomes in the United States: A 25-year National Cohort Study. Pediatr Transplant. 2021 Nov; 25(7):e14066.
    View in: PubMed
    Score: 0.049
  17. Iron Deficiency Is Associated with Adverse Outcomes in Pediatric Heart Failure. J Pediatr. 2020 01; 216:58-66.e1.
    View in: PubMed
    Score: 0.044
  18. Restrictive physiology is associated with poor outcomes in children with hypertrophic cardiomyopathy. Pediatr Cardiol. 2012 Jan; 33(1):141-9.
    View in: PubMed
    Score: 0.025
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.